The Pocket colposcope has 510k FDA clearance and has been successfully used in \~2500 unique patients globally in Duke and non-Duke protocols to date. 1054 women who are HPV(+) and planned to undergo treatment at four Ministry of Health-supported outpatient clinics in Kisumu County will be recruited to the study. After providing informed consent, participants will be proceed with colposcopy using the POCKET colposcope.
Women undergo Pocket-Assisted VIA (PA-VIA) and green light imaging using the Pocket Colposcope. Women will have biopsies taken of any suspicious lesions, or two biopsies taken in random locations if no lesions are visible. The locations of the biopsies will be based on provider impression. After their study-exams and biopsies are taken, women who are eligible for ablative treatment will be immediately treated in the clinic. Those with larger lesions or lesions concerning for invasive cancer will be referred to the local hospital for an excisional procedure. Once we have obtained enough images to develop the CARE algorithm, it will also be used to assist the provider in diagnosis. This record previously reflected only Phase 1 of Aim 3 of the grant. Phase 1 of Aim 3 was originally included within NCT04998318. The details for Phase 2 of Aim 3 were added to this record in September 2025 after approval.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
1,079
Each patient will receive treatment in order to prevent cervical cancer
Kenya Medical Research Institute
Nairobi, Kenya
RECRUITINGSensitivity of the Pocket CARE in detecting pre-cancer
Sensitivity will be reported as a percentage
Time frame: Day of imaging (Day 1)
Specificity of the Pocket CARE in detecting pre-cancer
Specificity will be reported as a percentage
Time frame: Day of imaging (Day 1)
Positive Predictive Value (PPV) of the Pocket CARE in detecting pre-cancer
PPV will be reported as a percentage
Time frame: Day of imaging (Day 1)
Negative Predictive Value (NPV) of the Pocket CARE in detecting pre-cancer
NPV will be reported as a percentage
Time frame: Day of imaging (Day 1)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.